Editverse · Clinical Decision Tools
Free CKD-EPI 2021 eGFR Calculator (2026)
This calculator estimates glomerular filtration rate (eGFR) — the standard measure of kidney function — using the 2021 CKD-EPI creatinine equation, the race-free formula the National Kidney Foundation and American Society of Nephrology jointly recommended to replace earlier race-adjusted versions. It takes age, sex, and serum creatinine and returns an eGFR in mL/min/1.73m², mapped to the KDIGO chronic kidney disease staging bands (G1 through G5). It is built for clinicians and researchers who need a quick, standardized eGFR — primary care, nephrology, internal medicine — for screening, monitoring, or drug-dosing decisions that depend on kidney function, understanding that a formal CKD diagnosis requires persistence over time plus an albuminuria category, not a single reading.
Clinical decision-support aid, not a substitute for clinical judgment. These tools implement published scoring criteria for education and workflow support. They are not a medical device and have not been reviewed by the FDA or any regulatory body. Every result should be interpreted by a qualified clinician in the context of the full clinical picture, not used as a standalone diagnostic or treatment decision.
Kidney function
CKD-EPI 2021 eGFR
Race-free creatinine-based estimated glomerular filtration rate — the equation the National Kidney Foundation and ASN task force recommended in 2021 to replace race-adjusted versions.
Inker LA, et al. N Engl J Med. 2021;385(19):1737–1749 · Delgado C, et al. Am J Kidney Dis. 2022;79(2):268–288 (NKF-ASN Task Force) · KDIGO 2024 CKD Guideline, Kidney Int. 2024;105(4S):S117–S314 (staging bands).
Worked example
Consider a 60-year-old man with a serum creatinine of 1.3 mg/dL. Applying the 2021 CKD-EPI equation for a male patient (k = 0.9, α = −0.302): creatinine divided by k is 1.3 ÷ 0.9 ≈ 1.44. Because that ratio is above 1, the equation’s first term (that same ratio raised to the male exponent of −0.302) contributes a factor of exactly 1, and its second term (the ratio raised to a fixed exponent of −1.200) contributes a factor of roughly 0.64.
Multiplying 142 by that 0.64, by an age term of 0.993860 (≈0.69), and by the male sex multiplier of 1.0 gives an eGFR of approximately 63 mL/min/1.73m². That value falls in the G2 band (60–89) — “mildly decreased” — which by itself is not a CKD diagnosis; it would need to persist on a repeat measurement at least three months later, alongside an albuminuria category, before it could be formally staged as chronic kidney disease. Enter age 60, sex male, and serum creatinine 1.3 in the calculator above to reproduce this result.
Methods
Estimated glomerular filtration rate was calculated with the 2021 CKD-EPI creatinine equation, a race-free formula incorporating age, sex, and serum creatinine, as derived by Inker et al. and endorsed by the National Kidney Foundation-American Society of Nephrology Task Force, with CKD stage assigned per the KDIGO 2024 guideline bands (Inker LA, et al. N Engl J Med. 2021;385(19):1737–1749; Delgado C, et al. Am J Kidney Dis. 2022;79(2):268–288).
Assumptions and when not to use this tool
This equation was derived and validated in adults; it is not intended for patients under 18. It assumes a clinically stable (steady-state) serum creatinine — it is not appropriate during acute kidney injury or any period of rapidly changing renal function, when creatinine has not yet equilibrated with the true filtration rate.
Like all creatinine-based equations, accuracy can be reduced at extremes of muscle mass or body habitus (for example, amputation, malnutrition, or very high muscle mass), since the equation infers filtration from creatinine generation, which itself depends on muscle mass. Finally, a single eGFR is a screening data point, not a CKD diagnosis: KDIGO criteria require abnormal kidney function or structure to persist for more than three months, evaluated alongside an albuminuria category, before chronic kidney disease can be formally staged. Because many anticoagulants used in atrial fibrillation are renally dosed, eGFR is also a routine input alongside stroke- and bleeding-risk scores such as CHA₂DS₂-VASc and HAS-BLED when choosing and dosing therapy.
Why was race removed from the eGFR equation?
The race-adjusted equations used a coefficient that assumed Black patients have systematically higher creatinine generation from muscle mass — a biological generalization that a joint 2021 National Kidney Foundation-American Society of Nephrology task force concluded was not an adequate proxy for the underlying physiology, and risked under-recognizing CKD severity in Black patients. The task force recommended the race-free 2021 CKD-EPI creatinine equation used in this calculator, which every patient’s eGFR is now calculated with, regardless of race.
What creatinine unit does this calculator expect?
Milligrams per deciliter (mg/dL). If your lab reports serum creatinine in micromoles per liter (µmol/L), divide by 88.4 before entering it — for example, 100 µmol/L is 1.13 mg/dL.
Is a single eGFR result enough to diagnose chronic kidney disease?
No. KDIGO criteria require evidence of reduced kidney function, or a structural marker such as albuminuria, to persist for more than three months. A single eGFR — however low — is a screening result that should prompt a repeat measurement and an albuminuria test, not an immediate CKD diagnosis.
Primary references
- Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385(19):1737–1749.
- Delgado C, Baweja M, Crews DC, et al. A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease. Am J Kidney Dis. 2022;79(2):268–288.
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD. Kidney Int. 2024;105(4S):S117–S314.
NHANES measures serum creatinine in most adult participants, making it a ready-made data source for kidney-function and CKD population-health research. Editverse’s NHANES Study service helps investigators design and execute that analysis end-to-end, from cohort definition through manuscript-ready statistical results.